Stay updated on IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Sign up to get notified when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.

Latest updates to the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.3 was added to the page, signaling a minor update to the record history. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed from the footer; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe Record History shows a new version entry (v3.3.2) and an older version (v3.2.0) in the study's revision log; these entries reflect updates to the history rather than changes to the study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRemoved the government funding lapse notice that warned information may not be up to date and directed users to cc.nih.gov and opm.gov for operating status.SummaryDifference0.8%

- Check55 days agoChange DetectedThe old and new screenshots show the same underlying study history content with only minor UI differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the previous version (v3.1.0).SummaryDifference12%

- Check91 days agoChange DetectedVersion updated from v3.0.2 (Deletions) to v3.1.0 (Additions).SummaryDifference0.3%

Stay in the know with updates to IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.